Click here to close now.




















Welcome!

News Feed Item

Spasticity Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

Spasticity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spasticity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spasticity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Spasticity Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Merz Pharma GmbH & Co. KgaA 36
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 36
GW Pharmaceuticals plc 37
Clinical Trial Overview of GW Pharmaceuticals plc 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Sun Pharma Advanced Research Company 39
Clinical Trial Overview of Sun Pharma Advanced Research Company 39
MediciNova, Inc. 40
Clinical Trial Overview of MediciNova, Inc. 40
Acorda Therapeutics, Inc. 41
Clinical Trial Overview of Acorda Therapeutics, Inc. 41
Concert Pharmaceuticals, Inc. 42
Clinical Trial Overview of Concert Pharmaceuticals, Inc. 42
Almirall, S.A. 43
Clinical Trial Overview of Almirall, S.A. 43
Clinical Trial Overview of Top Institutes / Government 44
Vanderbilt University 44
Clinical Trial Overview of Vanderbilt University 44
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
University of Minnesota 46
Clinical Trial Overview of University of Minnesota 46
University of Alberta 47
Clinical Trial Overview of University of Alberta 47
Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
University of Manitoba 49
Clinical Trial Overview of University of Manitoba 49
Princess Margaret Hospital 50
Clinical Trial Overview of Princess Margaret Hospital 50
Center for Medicinal Cannabis Research 51
Clinical Trial Overview of Center for Medicinal Cannabis Research 51
Department of Health, UK 52
Clinical Trial Overview of Department of Health, UK 52
University Hospital of Mont-Godinne 53
Clinical Trial Overview of University Hospital of Mont-Godinne 53
Five Key Clinical Profiles 54
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 119

List of Tables

Spasticity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 33
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 35
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 36
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 37
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014* 39
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014* 40
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 41
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Concert Pharmaceuticals, Inc., 2014* 42
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2014* 43
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 44
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 45
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 46
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014* 47
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 48
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 49
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014* 50
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Medicinal Cannabis Research, 2014* 51
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 52
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Mont-Godinne, 2014* 53

List of Figures

Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 118


Read the full report:
Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
Palerra, the cloud security automation company, announced enhanced support for Amazon AWS, allowing IT security and DevOps teams to automate activity and configuration monitoring, anomaly detection, and orchestrated remediation, thereby meeting compliance mandates within complex infrastructure deployments. "Monitoring and threat detection for AWS is a non-trivial task. While Amazon's flexible environment facilitates successful DevOps implementations, it adds another layer, which can become a ...
The speed of software changes in growing and large scale rapid-paced DevOps environments presents a challenge for continuous testing. Many organizations struggle to get this right. Practices that work for small scale continuous testing may not be sufficient as the requirements grow. In his session at DevOps Summit, Marc Hornbeek, Sr. Solutions Architect of DevOps continuous test solutions at Spirent Communications, explained the best practices of continuous testing at high scale, which is rele...
"We got started as search consultants. On the services side of the business we have help organizations save time and save money when they hit issues that everyone more or less hits when their data grows," noted Otis Gospodnetić, Founder of Sematext, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
Growth hacking is common for startups to make unheard-of progress in building their business. Career Hacks can help Geek Girls and those who support them (yes, that's you too, Dad!) to excel in this typically male-dominated world. Get ready to learn the facts: Is there a bias against women in the tech / developer communities? Why are women 50% of the workforce, but hold only 24% of the STEM or IT positions? Some beginnings of what to do about it! In her Opening Keynote at 16th Cloud Expo, S...
With SaaS use rampant across organizations, how can IT departments track company data and maintain security? More and more departments are commissioning their own solutions and bypassing IT. A cloud environment is amorphous and powerful, allowing you to set up solutions for all of your user needs: document sharing and collaboration, mobile access, e-mail, even industry-specific applications. In his session at 16th Cloud Expo, Shawn Mills, President and a founder of Green House Data, discussed h...
Delphix, the market leader in Data as a Service (DaaS), has been announced winner of the DevOps Solution Award at the prestigious Computing Vendor Excellence Awards in London. The awards celebrate the achievements of the technology vendors and service providers that are leading the field of enterprise IT. Delphix was recognised as the vendor demonstrating the most effective support of DevOps culture for its ability to improve time to market and collaboration between teams.
"Our biggest growth area has been the security services, the managed services - the things that differentiate us in the market that there is no client that's too small and there's no client that's too big," explained Paul Mazzucco, Chief Security Officer at TierPoint, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
The Cloud industry has moved from being more than just being able to provide infrastructure and management services on the Cloud. Enter a new era of Cloud computing where monetization’s services through the Cloud are an essential piece of strategy to feed your organizations bottom-line, your revenue and Profitability. In their session at 16th Cloud Expo, Ermanno Bonifazi, CEO & Founder of Solgenia, and Ian Khan, Global Strategic Positioning & Brand Manager at Solgenia, discussed how to easily o...
"We've just seen a huge influx of new partners coming into our ecosystem, and partners building unique offerings on top of our API set," explained Seth Bostock, Chief Executive Officer at IndependenceIT, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In his session at @ThingsExpo, James Kirkland, Red Hat's Chief Arch...
Sysdig has announced two significant milestones in its mission to bring infrastructure and application monitoring to the world of containers and microservices: a $10.7 million Series A funding led by Accel and Bain Capital Ventures (BCV); and the general availability of Sysdig Cloud, the first monitoring, alerting, and troubleshooting platform specializing in container visibility, which is already used by more than 30 enterprise customers. The funding will be used to drive adoption of Sysdig Clo...
The Software Defined Data Center (SDDC), which enables organizations to seamlessly run in a hybrid cloud model (public + private cloud), is here to stay. IDC estimates that the software-defined networking market will be valued at $3.7 billion by 2016. Security is a key component and benefit of the SDDC, and offers an opportunity to build security 'from the ground up' and weave it into the environment from day one. In his session at 16th Cloud Expo, Reuven Harrison, CTO and Co-Founder of Tufin,...
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists addressed this very serious issue of pro...
"We do data integration for B2B also application to application, and we do data management and enable Big Data," explained Pat Adamiak, Vice President, Product Marketing at Liaison Technologies, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.